Skip to main content
Andrea Kelly, MD, Pediatric Endocrinology, Philadelphia, PA

AndreaKellyMD

Pediatric Endocrinology Philadelphia, PA

Assistant Professor, Pediatrics, Perelman School of Medicine

Are you Dr. Kelly?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 84 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3401 Civic Center Blvd
    Children's Hospital Of Philadelphia - Endocrinology
    Philadelphia, PA 19104
    Phone+1 215-590-3174
    Fax+1 215-590-3053

Summary

  • Dr. Andrea Kelly, MD is a pediatric endocrinologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, and Pennsylvania Hospital.

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Endocrinology, 1998 - 2001
  • Tower Health/St. Christopher's Hospital for Children
    Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1995 - 1998
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1996 - 2024
  • American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study Finds
    Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study FindsJuly 21st, 2022
  • Business Summary | Business | Herald Dispatch.com
    Business Summary | Business | Herald Dispatch.comJuly 18th, 2021
  • Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
    Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual MeetingNovember 9th, 2020